Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
World Journal of Urology
Published in: World Journal of Urology 12/2019

01-12-2019 | Prostate Cancer | Original Article

Artificial urinary sphincter longevity following transurethral resection of the prostate in the setting of prostate cancer

Authors: Andrew J. Cohen, William Boysen, Kristine Kuchta, Sarah Faris, Jaclyn Milose

Published in: World Journal of Urology | Issue 12/2019

Login to get access

Abstract

Purpose

Refractory urinary incontinence after channel transurethral resection of the prostate (cTURP) (TURP in the setting of prostate cancer) is a rare occurrence treated with artificial urinary sphincter (AUS). We sought to characterize those patients receiving AUS after cTURP and understand device longevity.

Materials and methods

We identified patients who underwent cTURP and AUS placement in SEER-Medicare from 2002 to 2014. We analyzed factors affecting device longevity using multivariable Cox proportional hazard models. We performed propensity matching to accurately compare patients receiving AUS after cTURP to those receiving AUS after radical prostatectomy (RP).

Results

For patients undergoing cTURP, 201 out of 56,957 ultimately underwent AUS placement (< 0.5%). AUS after cTURP incurred a 48.4% rate of reoperation versus 30.9% after RP. Importantly, patients undergoing cTURP were significantly older than those undergoing RP [75 vs. 71 years of age (p < 0.01)]. At 3 years after insertion, 28.2% of patients after RP required reoperation compared to 37.8% of patients post-cTURP (p < 0.01). There were no detectable differences in revision rates for those patients who underwent traditional vs. laser cTURP. Patients with a history of radiation therapy had significantly shorter device survival. Even after propensity matching, patients receiving AUS after cTURP incurred more short-term complications compared to AUS after RP. Differences in device longevity were diminished after propensity match.

Conclusions

In the SEER-Medicare population, AUS after cTURP remains rare. While there is an increased risk of infectious complications, AUS after cTURP fared similarly to AUS after RP in terms of device longevity. A history of radiation therapy leads to worse outcome for all patients.
Appendix
Available only for authorised users
Literature
1.
Gratzke C et al (2015) EAU Guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67(6):1099–1109CrossRefPubMed
2.
Ficarra V et al (2012) Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol 62(3):405–417CrossRefPubMed
3.
Theodorou C, Moutzouris G, Floratos D, Plastiras D, Katsifotis C, Mertziotis N (1998) Incontinence after surgery for benign prostatic hypertrophy: the case for complex approach and treatment. Eur Urol 33(4):370–375CrossRefPubMed
4.
Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP)—incidence, management, and prevention. Eur Urol 50(5):969–980CrossRefPubMed
5.
Pickard R (2007) Male incontinence: pathophysiology and management. Indian J Urol IJU 23(2):179–180CrossRefPubMed
6.
7.
Heesakkers J, Farag F, Bauer RM, Sandhu J, De Ridder D, Stenzl A (2017) Pathophysiology and contributing factors in postprostatectomy incontinence: a review. Eur Urol 71(6):936–944CrossRefPubMed
8.
Friedl A et al (2017) The adjustable transobturator male system in stress urinary incontinence after transurethral resection of the prostate. Urology 109:184–189CrossRefPubMed
9.
Kretschmer A et al (2016) Long-term outcome of the retrourethral transobturator male sling after transurethral resection of the prostate. Int Neurourol J 20(4):335–341CrossRefPubMedPubMedCentral
10.
Hogewoning CRC, Meij LAM, Pelger RCM, Putter H, Krouwel EM, Elzevier HW (2017) Sling surgery for the treatment of urinary incontinence after transurethral resection of the prostate: new data on the virtue male sling and an evaluation of literature. Urology 100:187–192CrossRefPubMed
11.
Yafi FA, Powers MK, Zurawin J, Hellstrom WJG (2016) Contemporary review of artificial urinary sphincters for male stress urinary incontinence. Sex Med Rev 4(2):157–166CrossRefPubMed
12.
Gundian JC, Barrett DM, Parulkar BG (1993) Mayo Clinic experience with the AS800 artificial urinary sphincter for urinary incontinence after transurethral resection of prostate or open prostatectomy. Urology 41(4):318–321CrossRefPubMed
13.
Cohen AJ, Kuchta K, Park S, Milose J (2018) Patterns and timing of artificial urinary sphincter failure. World J Urol 36:939–945CrossRefPubMed
14.
Klabunde CN, Potosky AL, Legler JM, Warren JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53(12):1258–1267CrossRefPubMed
15.
Kuntz RM, Ahyai S, Lehrich K, Fayad A (2004) Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol 172(3):1012–1016CrossRefPubMed
16.
Bachmann A et al (2015) A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the goliath study. J Urol 193(2):570–578CrossRefPubMed
17.
Bruschini H, Simonetti R, Antunes AA, Srougi M (2011) Urinary incontinence following surgery for BPH: the role of aging on the incidence of bladder dysfunction. Int Braz J Urol 37(3):380–386 (discussion 387) CrossRefPubMed
18.
Punnen S, Cowan JE, Chan JM, Carroll PR, Cooperberg MR (2015) Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry. Eur Urol 68(4):600–608CrossRefPubMed
19.
20.
Viers BR, Linder BJ, Rivera ME, Rangel LJ, Ziegelmann MJ, Elliott DS (2016) Long-term quality of life and functional outcomes among primary and secondary artificial urinary sphincter implantations in men with stress urinary incontinence. J Urol 196(3):838–843CrossRefPubMed
21.
Polland A et al (2017) Preoperative symptoms predict continence after post-radiation transurethral resection of prostate. Can J Urol 24(4):8903–8909PubMed
22.
Viers BR et al (2016) The impact of diabetes mellitus and obesity on artificial urinary sphincter outcomes in men. Urology 98:176–182CrossRefPubMed
23.
Kaufman MR et al (2017) Prior radiation therapy decreases time to idiopathic erosion of artificial urinary sphincter: a multi-institutional analysis. J Urol 199:1037–1041CrossRefPubMed
24.
Zlotta AR, Giannakopoulos X, Maehlum O, Ostrem T, Schulman CC (2003) Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to 5 years from three centers. Eur Urol 44(1):89–93CrossRefPubMed
25.
Onyeji IC et al (2017) Impact of surgeon case volume on reoperation rates after inflatable penile prosthesis surgery. J Urol 197(1):223–229CrossRefPubMed
26.
Wilson SK, Zumbe J, Henry GD, Salem EA, Delk JR, Cleves MA (2007) Infection reduction using antibiotic-coated inflatable penile prosthesis. Urology 70(2):337–340CrossRefPubMed
27.
Simhan J et al (2015) 3.5 cm artificial urinary sphincter cuff erosion occurs predominantly in irradiated patients. J Urol 193(2):593–597CrossRefPubMed
28.
Suskind AM, Walter LC, Zhao S, Finlayson E (2017) Functional outcomes after transurethral resection of the prostate in nursing home residents. J Am Geriatr Soc 65(4):699–703CrossRefPubMed
29.
Gilling P, Anderson P, Tan A (2017) Aquablation of the prostate for symptomatic benign prostatic hyperplasia: 1-year results. J Urol 197(6):1565–1572CrossRefPubMed
30.
Umari P et al (2017) Robotic assisted simple prostatectomy versus holmium laser enucleation of the prostate for lower urinary tract symptoms in patients with large volume prostate: a comparative analysis from a high volume center. J Urol 197(4):1108–1114CrossRefPubMed
Metadata
Title
Artificial urinary sphincter longevity following transurethral resection of the prostate in the setting of prostate cancer
Authors
Andrew J. Cohen
William Boysen
Kristine Kuchta
Sarah Faris
Jaclyn Milose
Publication date
01-12-2019
Publisher
Springer Berlin Heidelberg
Published in
World Journal of Urology / Issue 12/2019
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-019-02684-z

Other articles of this Issue 12/2019

World Journal of Urology 12/2019 Go to the issue

Original Article

Impact of routine imaging in the diagnosis of recurrence for patients with localized and locally advanced renal tumor treated with nephrectomy

Letter to Editor

The use of buccal mucosa graft for correction of severe chordee and urethroplasty in proximal hypospadias repair

Original Article

En bloc resection improves the identification of muscularis mucosae in non-muscle invasive bladder cancer

Original Article

Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study

Original Article

Patients choose certainty over burden in bladder cancer surveillance

Original Article

Testosterone replacement therapy is associated with an increased risk of urolithiasis